FDA Questions ‘Key’ Evidence Provided in Johnson & Johnson Booster Shots
The Food and Drug Administration (FDA) is questioning the evidence provided by Johnson & Johnson in its application for authorization of its coronavirus booster shot, according to a document released prior to the October 15 meeting with FDA vaccine advisers.
